510(k) Report

510(k) · Cleared

Cleared

Sparrow Ascent

K251246510(k) TraditionalCleared Aug 25, 2025125-day reviewClass II21 CFR 882.5896

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Spark Biomedical, Inc. · PZR Percutaneous Nerve Stimulator For Opioid Withdrawal

Cleared on Aug 25, 2025 as substantially equivalent to K230796 (Spark Biomedical, Inc., 2023) after a 125-day review. Its family tree reaches back 3 generations to 2017.

Decided
Aug 25, 2025
Review
125 days
Class
Class II
Product code
PZR
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to DEN170018 (2017). No later device cites it as a predicate yet.

  1. Root · 3 generations backDEN170018 NSS-2 SystemInnovative Health Solutions (Ihs), Inc. · 2017
  2. 2 generations backK201873 Sparrow Therapy SystemSpark Biomedical, Inc. · 2021
  3. 1 generation backK230796 Sparrow AscentSpark Biomedical, Inc. · 2023 · Recalled
  4. This deviceK251246 Sparrow AscentSpark Biomedical, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3DEN170018NSS-2 SystemInnovative Health Solutions (Ihs), Inc.2017—
−2K201873Sparrow Therapy SystemSpark Biomedical, Inc.2021—
−1K230796Sparrow AscentSpark Biomedical, Inc.20231
0 (this device)K251246Sparrow AscentSpark Biomedical, Inc.2025—
FIG. 1 — Lineage of K251246, 2017–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PZR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PZR device

  1. #1 K233166 NET Recovery Corp/NET Devicescore 7.7 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K230796Sparrow Ascent
Summary page 5
…Manufacturer Reg Number Sparrow Ascent / PZR / K230796 Primary Predicate Spark Biomedical, Inc.…
Spark Biomedical, Inc.20231
†K233166NET Recovery Corp/NET DeviceNet Recovery2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 2.5 years on median.
  • 1 of the 3 ancestors has a recall of any class.

How does its category compare?

All PZR devices

PZR Percutaneous Nerve Stimulator For Opioid Withdrawal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · PZR

1in 2025

2017: 12018: 12021: 22022: 12023: 12024: 12025: 1
2007high 2 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PZR

Too few PZR 510(k)s in any year since 2007 to give a median.

Recalls per year · PZR

No recall names PZR since 2007.

Adverse event reports per year · PZR

No MAUDE report names PZR since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20181—00
20190—00
20200—00
20212—00
20221—00
20231—00
20241—00
20251—00
20260—0—

What is it indicated for?

The Sparrow Ascent is a transcutaneous nerve field stimulator that is intended to be used in patients experiencing opioid withdrawal in conjunction with standard symptomatic medications and other therapies for opioid withdrawal symptoms under the supervision of trained clinical personnel.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251246: Sparrow Ascent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K251246

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026